Registry of Patients Prescribed Anticoagulation
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT03504007
- Status
- Recruiting
Conditions
- Acute Deep Vein Thrombosis
- Acute Pulmonary Embolism
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Gonda Vascular Center- Thrombophilia Clinic at Mayo Clinic in Rochester, Minnesota utilizes a standardized, guideline-directed, yet patient-oriented approach for treating patients diagnosed with venous thromboembolism (VTE).This study is the ongoing registry of clinical practice with standardized approach to patient assessment and therapy. As most of registries it does not have any definite number of recruited subjects or the date of study completion but provides anticipated number of recruited subjects and the time of anticipated enrolment which was provided only because of formal requirement related to structure of ClinicalTrials.gov website. This number will be updated and upgraded as we continue this registry. The rates of VTE recurrence, major bleeding, clinically relevant non-major bleeding (CRNMB) and survival in patients treated with anticoagulation for acute VTE are assessed during prospective observation. VTE cases include an acute deep vein thrombosis (DVT) of lower or upper extremities, splanchnic veins, gonadal, renal, cerebral veins thrombosis and pulmonary embolism (PE). Therapy includes the whole spectrum of FDA approved anticoagulants such as "classic" agents: warfarin and heparinoids and the newer direct oral anticoagulants (DOACs) such as rivaroxaban, dabigatran, apixaban, and edoxaban.
Key Dates
- Start date
- Mar 1, 2013
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2033
- Completion
- Mar 31, 2033
Study Design
- Enrollment
- 10,000 participants (estimated)
Primary Outcome Measure
Incidence of symptomatic, recurrent VTE. Incidence of major bleeding [ Time Frame: 10 years ]
Central Contacts
- Damon Houghton, MD, MS507-266-6717
- Danielle Vlazny, P.A.-C., M.S.507-266-6717
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Damon Houghton, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
Related Studies
- Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill PatientsEnrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- 129Xe MRI CardiopulmonaryPHASE2 · Recruiting · Bastiaan Driehuys · Durham, North Carolina
- Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary EmbolismRecruiting · University of Rochester · Rochester, New York